The worldwide CAR T-cell therapy market is experiencing significant growth, driven by rising demand for advanced cancer treatment options. This rapid expansion is fueled by contributing forces such as the authorization of CAR T-cell therapies for diverse treatments, advancements in manufacturing technologies, and expanding research and development